Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G P Miljanich

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Biochemistry|April 8, 1997
An alpha-helical minimal binding domain within the H3 domain of syntaxin is required for SNAP-25 bindingP Zhong, Y A Chen, D Tam, et al.
Journal De Physiologie|January 1, 1982
Nerve terminal components from normal and denervated Narcine electric organJ E Hooper, J W Deutsch, G P Miljanich, et al.
Molecular and Cellular Neurosciences|June 1, 1994
Characterization of the binding of omega-conopeptides to different classes of non-L-type neuronal calcium channelsR Kristipati, L Nádasdi, K Tarczy-Hornoch, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 13, 2010
Identification of phase-I metabolites and chronic toxicity study of the Kv1.3 blocker PAP-1 (5-(4-phenoxybutoxy)psoralen) in the ratB Hao, Z-W Chen, X-J Zhou, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1995
Differential blockade of voltage-sensitive calcium channels at the mouse neuromuscular junction by novel omega-conopeptides and omega-agatoxin-IVAS S Bowersox, G P Miljanich, Y Sugiura, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1983
A synaptic vesicle antigen is restricted to the junctional region of the presynaptic plasma membraneK M Buckley, E S Schweitzer, G P Miljanich, et al.
The New England Journal of Medicine|June 1, 1995
Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromesV A Lennon, T J Kryzer, G E Griesmann, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 1999
Structure-activity relationship at the proximal phenyl group in a series of non-peptidyl N-type calcium channel antagonistsT R Ryder, L Y Hu, M F Rafferty, et al.
Bioorganic & Medicinal Chemistry|July 15, 2000
The discovery of [1-(4-dimethylamino-benzyl)-piperidin-4-yl]-[4-(3,3-dimethylbutyl)-phen yl]-(3-methyl-but-2-enyl)-amine, an N-type Ca+2 channel blocker with oral activity for analgesiaL Y Hu, T R Ryder, M F Rafferty, et al.
Drug Design and Discovery|May 12, 2000
Structure-activity relationship at the leucine side chain in a series of N,N-dialkyldipeptidyl-amines as N-type calcium channel blockersT R Ryder, L Y Hu, M F Rafferty, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Biochemistry|April 8, 1997
An alpha-helical minimal binding domain within the H3 domain of syntaxin is required for SNAP-25 bindingP Zhong, Y A Chen, D Tam, et al.
Journal De Physiologie|January 1, 1982
Nerve terminal components from normal and denervated Narcine electric organJ E Hooper, J W Deutsch, G P Miljanich, et al.
Molecular and Cellular Neurosciences|June 1, 1994
Characterization of the binding of omega-conopeptides to different classes of non-L-type neuronal calcium channelsR Kristipati, L Nádasdi, K Tarczy-Hornoch, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 13, 2010
Identification of phase-I metabolites and chronic toxicity study of the Kv1.3 blocker PAP-1 (5-(4-phenoxybutoxy)psoralen) in the ratB Hao, Z-W Chen, X-J Zhou, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1995
Differential blockade of voltage-sensitive calcium channels at the mouse neuromuscular junction by novel omega-conopeptides and omega-agatoxin-IVAS S Bowersox, G P Miljanich, Y Sugiura, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1983
A synaptic vesicle antigen is restricted to the junctional region of the presynaptic plasma membraneK M Buckley, E S Schweitzer, G P Miljanich, et al.
The New England Journal of Medicine|June 1, 1995
Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromesV A Lennon, T J Kryzer, G E Griesmann, et al.
Bioorganic & Medicinal Chemistry Letters|September 7, 1999
Structure-activity relationship at the proximal phenyl group in a series of non-peptidyl N-type calcium channel antagonistsT R Ryder, L Y Hu, M F Rafferty, et al.
Bioorganic & Medicinal Chemistry|July 15, 2000
The discovery of [1-(4-dimethylamino-benzyl)-piperidin-4-yl]-[4-(3,3-dimethylbutyl)-phen yl]-(3-methyl-but-2-enyl)-amine, an N-type Ca+2 channel blocker with oral activity for analgesiaL Y Hu, T R Ryder, M F Rafferty, et al.
Drug Design and Discovery|May 12, 2000
Structure-activity relationship at the leucine side chain in a series of N,N-dialkyldipeptidyl-amines as N-type calcium channel blockersT R Ryder, L Y Hu, M F Rafferty, et al.
Pageof 4